• 1
    Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002; 17: 629638.
  • 2
    Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annual Review of Immunology 2002; 20: 495549.
  • 3
    Strober W, Fuss IJ, Ehrhardt RO, Neurath M, Boirivant M, Ludviksson BR. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scandinavian Journal of Immunology 1998; 48: 453458.
  • 4
    Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterization of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency. Digestion 2000; 62: 240248.
  • 5
    Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, Koteliansky VE, Senninger N, Granger DN, De Fougerolles AR. Collagen-binding integrin a1ß1 regulates intestinal inflammation in experimental colitis. J Clin Invest 2002; 110: 17731782.
  • 6
    Strobach RS, Ross AH, Markin RS, Zetterman RK, Linder J. Neural patterns in inflammatory bowel disease: an immunohistochemical survey. Mod Pathol 1990; 3: 488493.
  • 7
    McCafferty D, Sharkey K, Wallace J. Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol, GI and Liver Physiol 1994; 266: G560G567.
  • 8
    Kihara N, De La Fuente SG, Fujino K, Takahashi T, Pappas TN, Mantyh CR. Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats. Gut 2003; 52: 713719.
  • 9
    Kimball ES, Wallace NH, Schneider CR, D'Andrea MR, Hornby PJ. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice. Neurogastroenterol Motil 2004; 16: 811818.
  • 10
    Linden DR, Sharkey KA, Mawe GM. Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon. J Physiol 2003; 547: 589601.
  • 11
    Banvolgyi A, Pozsgai G, Brain SD, Helyes ZS, Szolcsanyi J, Ghosh M, Melegh B, Pinter E. Mustard oil induces a transient receptor potential vanilloid 1 receptor-independent neurogenic inflammation and a non-neurogenic cellular inflammatory component in mice. Neuroscience 2004; 125: 449459.
  • 12
    Inoue H, Asaka T, Nagata N, Koshihara Y. Mechanism of mustard oil-induced skin inflammation in mice. European Journal of Pharmacology 1997; 333: 231240.
  • 13
    Laird JMA, Martinez-Caro L, Garcia-Nicas E, Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 2001; 92: 335342.
  • 14
    Palecek J, Willis WD. The dorsal column pathway facilitates visceromotor responses to colorectal distention after colon inflammation in rats. Pain 2003; 104: 501507.
  • 15
    Bereiter DA, Bereiter DF, Hirata H. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat. Pain 2002; 99: 547556.
  • 16
    Laird JMA, Olivar T, Roza C, De Felipe C, Hunt SP, Cervero F. Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience 2000; 98: 345352.
  • 17
    Lu Y, Westlund KN. Effects of baclofen on colon inflammation-induced Fos, CGRP and SP expression in spinal cord and brainstem. Brain Research 2001; 889: 118130.
  • 18
    Yu, XM, Sessle BJ, Vernon H, Hu J. Administration of opiate antagonist naloxone induces recurrence of increased jaw muscle activities related to inflammatory irritant application to rat temporomandibular joint region. J Neurophysiol 1994; 72: 14301433.
  • 19
    Kimball ES, Palmer JM, D'Andrea MR, Hornby PJ, Wade PR. Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice. Am J Physiol Gastrointest Liver Physiol 2005; 288: G12661273.
  • 20
    Kimball ES, Schneider CR, Wallace NH, Hornby PJ. Agonists of Cannabinoid Receptor 1 and 2 Inhibit Experimental Colitis Induced by Oil of Mustard and by Dextran Sulfate Sodium. Am J Physiol Gastrointest Liver Physiol, 2006; 291: G364G371.
  • 21
    Jordt SE, Bautista DM, Chuang H-H, McKemy DD, Zygmunt PM, Hogestatt ED, Meng ID, Julius, D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. NATURE 2004; 427: 260265.
  • 22
    Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annual Review of Neuroscience 2001; 24: 487517.
  • 23
    Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999; 398: 436441.
  • 24
    Li M, Bullock C, Knauer D, Ehlert F, Zhou Q. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 2001; 59: 692698.
  • 25
    Dorsch M, Qiu Y, Soler D, Frank N, Duong T, Goodearl A, O'Neil S, Lora J, Fraser CC. PK1/EG-VEGF induces monocyte differentiation and activation. J Leukoc Biol 2005; 78: 426434.
  • 26
    Boudarine M, Yegorov O, Sterling-Dubrovsky A, Devi LA, Berman Y. Developmental Changes in Opioid Peptides and Their Receptors in Cpefat/Cpefat Mice Lacking Peptide Processing Enzyme Carboxypeptidase E. J Pharm Exp Ther 2002; 303: 13171324.
  • 27
    Si-Tahar M, Merlin D, Sitaraman S, Madara JL. Constitutive and Regulated Secretion of Secretory Leukocyte Proteinase Inhibitor by Human Intestinal Epithelial Cells. Gastroenterology 2000; 118: 10611071.
  • 28
    Dux MJG, Sann H, Pierau FK. Inhibition of the neurogenic inflammatory response by lidocaine in rat skin. Inflamm Res 1996; 45: 1013.
  • 29
    Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 1967; 31: 138151.
  • 30
    Swain M, Blennerhassett P, Collins S. Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology 1991; 100: 675682.
  • 31
    Xia Y, Hu H-Z, Liu S, Ren J, Zafirov DH, Wood JD. IL-1β and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pigenteric nervous system. J Clin Invest 1999; 103: 13091316.
  • 32
    Linden DR, Chen JX, Gershon MD, Sharkey KA, Mawe GM. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003; 285: G207216.
  • 33
    McVey DC, Vigna SR. The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats. Peptides 2001; 22: 14391446.
  • 34
    Wright K, Rooney N, Feeney M, Tate J, Robertson D, Welham M, Ward S. Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing. Gastroenterology 2005; 129: 437453.
  • 35
    Blandizzi C, Fornai M, Colucci R, Baschiera F, Barbara G, De Giorgio R, De Ponti F, Breschi MC, Del Tacca M. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol 2003; 139: 309320.
  • 36
    Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M, Lutz B. The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 2004; 113: 12021209.
  • 37
    Stucchi AF, Shofer S, Leeman S, Materne O, Beer E, McClung J, Shebani K, Moore F, O'Brien M, Becker JM. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. American Journal of Physiology-Gastrointestinal & Liver Physiology 2000; 279: G12981306.
  • 38
    Holzer P, Holzer-Petsch U. Tachkykinins in the gut, Part II. Roles in neural excitation, secretion and inflammation. Pharmacology & Therapeutics 1997; 73: 219263.
  • 39
    Evangelista S, Maggi M, Renzetti AR. Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats. Neuropeptides 1996; 30: 425428.
  • 40
    Evangelista S, Meli A. Influence of capsaicin-sensitive fibres on experimentally-induced colitis in rats. J Pharm Pharmacol 1989; 41: 574575.
  • 41
    Wallace JL, McCafferty DM, Sharkey KA. Lack of beneficial effect of a tachykinin receptor antagonist in experimental colitis. Regul Pept 1998; 73: 95101.
  • 42
    Cutrufo C, Evangelista S, Cirillo R, Ciucci A, Conte B, Lopez G, Manzini S, Maggi CA. Effect of MEN 11467, a new tachykinin NK1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs. Eur J Pharmacol 1999; 374: 277283.
  • 43
    Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O'Keane JC, Snider RM, Leeman SE. CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci U S A 1994; 91: 947951.